|
FDA approves Veinwave for U.S. |
|
|
|
|
Although more than 1,000 physicians in Europe have been using Veinwave for more than eight years, the FDA has only recently cleared the use of the device for eliminating spider veins of the lower extremities and telangiectasia.
Although more than 1,000 physicians in Europe have been using Veinwave for more than eight years, the FDA has only recently cleared the use of the device for eliminating spider veins of the lower extremities and telangiectasia. Designed primarily for vascular surgeons, dermatologists and plastic surgeons, Veinwave (www.VeinwaveUSA.com) uses a process called “Unipolar Thermo-coagulation (UTC).” A unique, high-frequency energy is applied to the affected area, which causes the vein walls to collapse.
Veinwave’s ultra-fine, insulated probe permits a highly targeted treatment that doesn’t irritate the surrounding skin. There is only a slight discomfort, so there is no need for anesthetic creams or pain medications. Also, the Veinwave doesn’t carry a risk of long-term scarring and is over in 15 minutes. Sclerotherapy provides successful treatment on the larger leg veins. As a combination therapy, Veinwave is the perfect compliment to sclerotherapy for the smaller veins. |